Determination of the genomic sequence of Mycoplasma gallisepticum : a report for the Rural Industries Research and Development Corporation / by GF Browning and PF Markham
Although disease due to Mycoplasma gallisepticum is effectively controlled by the use of strain ts-11 as a vaccine, this cannot be presumed to continue indefinitely, as past experience with Marek's disease vaccines has demonstrated. In addition, recent work in this research group's laboratory has demonstrated that M. gallisepticum vaccine strains may be used to deliver antigens to the respiratory tract of the bird. The aim of this project was to collaborate with several international laboratories in the determination and analysis of the genomic sequence of Mycoplasma gallisepticum
Notes
"December 2004."
"RIRDC project no. UM-45J."
"Chicken Meat R&D"--Cover
"Established industries"--Cover
Bibliography
Bibliography: pages 7-8
Notes
Also available in an electronic version on the Internet. Address as of 28/02/05: http://www.rirdc.gov.au/reports/CME/04-140.pdf
System requirements: Adobe Acrobat Reader required to view/print PDF files
2004 Rural Industries Research and Development Corporation